Seminars in Nuclear Medicine

Papers
(The TQCC of Seminars in Nuclear Medicine is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Theranostics in Lung Neuroendocrine Tumors133
Letter from the Guest Editors119
Letter from the Editors103
FAPI-PET in Cardiovascular Disease69
Sentinel Lymph Node Methods in Breast Cancer57
Non-FDG hypoxia tracers54
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques52
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update45
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies44
PET/CT in the Imaging of CNS Tumors43
Imaging of Invasive Fungal Infections- The Role of PET/CT42
The Role of Nuclear Medicine in Benign Thyroid Disease41
Autoimmune Thyroid Diseases41
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer38
Prognostic Value of PSMA PET/CT in Prostate Cancer35
Molecular Imaging in Inflammatory Bowel Disease35
Imaging for Radiation Planning in Breast Cancer35
Artificial Intelligence for Drug Discovery: An Update and Future Prospects35
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled34
Global experience in brain amyloid imaging33
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity33
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy33
Total-Body PET/CT: A Role of Artificial Intelligence?33
The Evolution of Artificial Intelligence in Nuclear Medicine31
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects31
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers30
Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-1928
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma28
PET/MR Technology: Advancement and Challenges27
New Approaches for Imaging Bacteria27
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis26
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects25
Letter From the Editors24
Expanding Role for Gallium-68 PET Imaging in Oncology24
Letter from the Guest Editors24
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I24
Use of Radionuclide-Based Imaging Methods in Breast Cancer23
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology23
Total-body PET/CT – First Clinical Experiences and Future Perspectives23
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices22
Update on Pediatric Nuclear Medicine in Acute Care21
18F-Fluoride PET/CT—Updates21
Standardized PSMA-PET Imaging of Advanced Prostate Cancer21
Letter from the Editors20
Impact of COVID-19 on Nuclear Medicine in Asia20
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine20
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?19
Radiolabeled Somatostatin Analogs for Cancer Imaging19
Nuclear Medicine Preclinical Research: The Role of Cell Cultures19
FDG PET/CT for Staging Lung Carcinoma: An Update18
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review17
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases17
The Clinical Utility of Molecular Imaging in COVID-19: An Update17
Safe Pulmonary Scintigraphy in the Era of COVID-1917
Functional Imaging of Testicular Torsion17
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine17
The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment17
Artificial Intelligence Augmented Cerebral Nuclear Imaging16
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?16
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace16
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends16
The Impact of COVID-19 on Nuclear Medicine in Europe16
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma16
Targeted Radiopharmaceutical Therapy for Bone Metastases16
Artificial Intelligence and Workforce Diversity in Nuclear Medicine16
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET16
FDG-PET/CT Variants and Pitfalls in Haematological Malignancies15
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget15
Letter from the Editors15
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides14
A Role of Non-FDG Tracers in Lung Cancer?14
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy14
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma14
FDG-PET/CT of COVID-19 and Other Lung Infections14
Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case14
Letter From the Guest Editors14
PET/CT Variants and Pitfalls in Gynecological Cancers14
Prostate Cancer Theranostics With 177Lu-PSMA14
0.046823978424072